FRACTYL HEALTH, INC. - 8-K Filing

Fractyl Health reports Q3 2026 results, announces 45% workforce reduction, and targets FDA De Novo submission for Revita in late Q4 2026. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 12, 2026, 21:05 UTC

Tickers: $GUTS

Read the full article at SEC EDGAR

Part of the story FRACTYL HEALTH, INC. - 8-K Filing (3 articles)

More Regulatory news

FACT II Acquisition Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:46 UTC
Marblegate Capital Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 21:46 UTC
Greenland Mines Ltd - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
InspireMD, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
InspireMD, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
Pinnacle Acquisition Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 21:45 UTC
SUTRO BIOPHARMA, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
Aeluma, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
ASTEC INDUSTRIES INC - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
Live Oak Bancshares, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:44 UTC